Anticoagulation management during multivessel coronary artery bypass grafting: A randomized trial comparing individualized heparin management and conventional hemostasis management

Journal of Thrombosis and Haemostasis

Volumn 13, Issue 7, 2015, Pages 1196-1206

  Hoenicka, M ^a   Rupp, P ^a   Muller Eising K ^a   Deininger, S ^a   Kunert, A ^a   Liebold, A ^a   Gorki, H ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Coronary artery bypass grafting; Heparin; Postoperative hemorrhage; Protamine sulfate; Thromboelastography

Indexed keywords

ANTICOAGULANT AGENT; HEMOSTATIC AGENT; HEPARIN; PROTAMINE; HEPARIN ANTAGONIST;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TIME; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG RESPONSE; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MIDDLE AGED; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; THROMBOELASTOMETRY; ADVERSE EFFECTS; BLOOD; BLOOD CLOTTING TEST; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; DRUG MONITORING; GERMANY; PERIOPERATIVE PERIOD; PREDICTIVE VALUE; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; BLOOD COAGULATION TESTS; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; ERYTHROCYTE TRANSFUSION; FEMALE; GERMANY; HEMOSTASIS; HEMOSTATICS; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PLATELET COUNT; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE OF TESTS; PROTAMINES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84935419651     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12999     Document Type: Article

References (22)

1. Hattersley PG. Progress report: the activated coagulation time of whole blood (ACT). Am J Clin Pathol 1976; 66: 899-904.
2. Kesteven PJ, Pasaoglu I, Williams BT, Savidge GF. Significance of the whole blood activated clotting time in cardiopulmonary bypass. J Cardiovasc Surg (Torino) 1986; 27: 85-9.
3. Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 1975; 69: 685-9.
4. Aziz KAA, Masood O, Hoschtitzky JA, Ronald A. Does use of the Hepcon point-of-care coagulation monitor to optimise heparin and protamine dosage for cardiopulmonary bypass decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg 2006; 5: 469-82.
5. Koster A, Fischer T, Praus M, Haberzettl H, Kuebler WM, Hetzer R, Kuppe H. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology 2002; 97: 837-41.
6. Cliffton EE. Hypercoagulability and the hemorrhagic state with extra-corporeal circulation. Bibl Haematol 1968; 29: 841-57.
7. Boisclair MD, Lane DA, Philippou H, Esnouf MP, Sheikh S, Hunt B, Smith KJ. Mechanisms of thrombin generation duringsurgery and cardiopulmonary bypass. Blood 1993; 82: 3350-7.
8. Morisaki A, Nakahira A, Sasaki Y, Hirai H, Okada Y, Suehiro S, Shibata T. Is elimination of cardiotomy suction preferable in aortic valve replacement? Assessment of perioperative coagulation, fibrinolysis and inflammation. Interact Cardiovasc Thorac Surg 2013; 17: 507-14.
9. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2014.
10. Despotis GJ, Joist JH, Hogue CW Jr, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1995; 110: 46-54.
11. Noui N, Zogheib E, Walczak K, Werbrouck A, Amar AB, Dupont H, Caus T, Remadi JP. Anticoagulation monitoring during extracorporeal circulation with the Hepcon/HMS device. Perfusion 2012; 27: 214-20.
12. Slight RD, Buell R, Nzewi OC, McClelland DBL, Mankad PS. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2008; 22: 47-52.
13. Garvin S, FitzGerald DC, Despotis G, Shekar P, Body SC. Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements. Anesth Analg 2010; 111: 849-55.
14. Slaughter TF, LeBleu TH, Douglas JM Jr, Leslie JB, Parker JK, Greenberg CS. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers. Anesthesiology 1994; 80: 520-6.
15. Sniecinski RM, Chandler WL. Activation of the hemostatic system during cardiopulmonary bypass. Anesth Analg 2011; 113: 1319-33.
16. Muedra V, Bonanad S, Gómez M, Villalonga V, Sánchez F, Llopis JE. Relationships between antithrombin activity, anticoagulant efficacy of heparin therapy and perioperative variables in patients undergoing cardiac surgery requiring cardiopulmonary bypass. Perfusion 2011; 26: 487-95.
17. Paparella D, Semeraro F, Scrascia G, Galeone A, Ammollo CT, Kounakis G, de LucaTupputi Schinosa L, Semeraro N, Colucci M. Coagulation-fibrinolysis changes during off-pump bypass: effect of two heparin doses. Ann Thorac Surg 2010; 89: 421-7.
18. Khan NU, Wayne CK, Barker J, Strang T. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph. Eur J Anaesthesiol 2010; 27: 624-7.
19. Taneja R, Marwaha G, Sinha P, Quantz M, Stitt L, Gao R, Subramanian S, Schaus M, Keeney M, Chin-Yee I, Murkin J. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery. Can J Anaesth 2009; 56: 489-96.
20. Galeone A, Rotunno C, Guida P, Bisceglie A, Rubino G, Schinosa LdLT, Paparella D. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery. J Cardiothorac Vasc Anesth 2013; 27: 853-8.
21. Garvin S, Fitzgerald D, Muehlschlegel JD, Perry TE, Fox AA, Shernan SK, Collard CD, Aranki S, Body SC. Heparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations. Anesth Analg 2010; 111: 856-61.
22. Campeau L. Letter: grading of angina pectoris. Circulation 1976; 54: 522-3.